Login / Signup

Development of core outcome sets for clinical trials in temporomandibular disorders: A study protocol.

Natália Dos Reis FerreiraCarlos Miguel Machado MartoAleli Tôrres de OliveiraMaria João RodriguesMarcos Fabio Henriques DosSantos
Published in: PloS one (2022)
The implementation of this protocol will determine the COS-TMD, which will be made available for use in all TMD clinical studies. The use of COS when planning and reporting TMD clinical trials will reduce the risk of publication bias and enable proper comparison of results found by different studies.
Keyphrases
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase ii
  • open label
  • healthcare
  • primary care
  • double blind
  • phase iii
  • adverse drug
  • emergency department
  • placebo controlled
  • clinical evaluation